Abstract
Aspergillus terreus may colonize the airways of patients with cystic fibrosis (CF). Whether this merits antifungal treatment is still unclear due to heterogeneous reports regarding its pathogenic potential. Although allergic manifestations are documented, invasive aspergillosis (IA) caused by A. terreus has not been described. We present here one case of probable IA caused by A. terreus, highlighting its role as an emerging agent of IA in CF patients. Voriconazole was effective, and the patient was healthy after 12 weeks of treatment. Serial determination of serum galactomannan level and periodic cultures from respiratory specimens may help in monitoring CF patients by identifying such pathogens. Further studies on the fungal species colonizing the CF airways are warranted, especially in India. This case report suggests A. terreus as a potential agent of IA which should not be ignored, particularly in this patient group.
Similar content being viewed by others
References
Ashavaid TF, Raghavan R, Dhairyawan P, et al. Cystic fibrosis in India: a systematic review. J Assoc Phys India. 2012;60:39–41.
Burgel PR, Paugam A, Hubert D, Martin C. Aspergillus fumigatus in the cystic fibrosis lung: pros and cons of azole therapy. Infect Drug Resist. 2016;9:229–38.
Maturu VN, Agarwal R. Prevalence of Aspergillus sensitization and allergic bronchopulmonary aspergillosis in cystic fibrosis: systematic review and meta-analysis. Clin Exp Allergy. 2015;45:1765–78.
Massam J, Bitnun A, Solomon M, et al. Invasive aspergillosis in cystic fibrosis: a fatal case in an adolescent and review of the literature. Pediatr Infect Dis J. 2011;30:178–80.
Mosquera RA, Estrada L, Clements RM, Jo CK. Early diagnosis and treatment of invasive pulmonary aspergillosis in a patient with cystic fibrosis. BMJ Case Rep. 2013;2013:bcr2013201360.
Neil LC, Kunimoto BD. An unusual case of pulmonary invasive aspergillosis and aspergilloma cured with voriconazole in a patient with cystic fibrosis. Clin Infect Dis. 2002;35:e106–10.
Geltnera C, Lass-Florl C. Invasive pulmonary aspergillosis in organ transplants—focus on lung transplants. Respir Investig. 2016;54:76–84.
Farrell PM, Rosenstein BJ, White TB, et al. Cystic Fibrosis Foundation. Guidelines for diagnosis of cystic fibrosis in newborns through older adults: cystic Fibrosis Foundation consensus report. J Pediatr. 2008;153:S4–14.
Stevens DA, Moss RB, Kurup VP, et al. Allergic bronchopulmonary aspergillosis in cystic fibrosis—state of the art: cystic Fibrosis Foundation Consensus Conference. Clin Infect Dis. 2003;37(Suppl 3):S225–64.
CLSI. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; approved standard-second edition. CLSI document M38-A2. Wayne, PA: Clinical and Laboratory Standards Institute 2008.
Middleton PG, Meyer W. Fungal infections and treatment in cystic fibrosis. Curr Opin Pulm Med. 2013;19:670–5.
Chakrabarti A, Chatterjee SS, Das A, et al. Invasive aspergillosis in developing countries. Med Mycol. 2011;49(Suppl 1):S35–47.
Thayanidhi P, Subramanian A, Kindo AJ. Aspergillus terreus: An emerging pathogen. A case series. J Acad Clin Microbiol. 2014;16:96–9.
Rougeron A, Giraud S, Razafimandimby B, Meis JF, Bouchara JP, Klaassen CH. Different colonization patterns of Aspergillus terreus in patients with cystic fibrosis. Clin Microbiol Infect. 2014;20:327–33.
Dunne K, Prior AR, Murphy K, et al. Emergence of persistent Aspergillus terreus colonisation in a child with cystic fibrosis. Med Mycol Case Rep. 2015;9:26–30.
Cohen TS, Prince A. Cystic fibrosis: a mucosal immunodeficiency syndrome. Nat Med. 2012;5:509–19.
Noni M, Katelari A, Dimopoulos G, et al. Inhaled corticosteroids and Aspergillus fumigatus isolation in cystic fibrosis. Med Mycol. 2014;52:715–22.
Warren TA, Yau Y, Ratjen F, Tullis E, Waters V. Serum galactomannan in cystic fibrosis patients colonized with Aspergillus species. Med Mycol. 2012;50:658–68.
Ray H, Gomes MZR, Helou GE, et al. Invasive aspergillosis caused by Aspergillus terreus: an emerging opportunistic infection with poor outcome independent of azole therapy. J Antimicrob Chemother. 2014;69:3148–55.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical Standards
This study was based on retrospective data analysis and did not include any intervention besides standard of care during hospitalization.
Informed Consent
Informed consent was obtained from the parents of the patient included in this study.
Additional information
Handling Editor: J.-P. Bouchara.
Rights and permissions
About this article
Cite this article
Singh, S., Kaur, H., Singh, M. et al. Aspergillus terreus Causing Probable Invasive Aspergillosis in a Patient with Cystic Fibrosis. Mycopathologia 184, 151–154 (2019). https://doi.org/10.1007/s11046-018-0294-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11046-018-0294-1